559
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Disseminated intravascular coagulation in children with cancer: A systematic review

, & ORCID Icon
Pages 390-411 | Received 16 Jul 2019, Accepted 19 Feb 2020, Published online: 23 Mar 2020

References

  • Levi M, Sivapalaratnam S. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Rev Hematol 2018;11(8):663–672. doi:10.1080/17474086.2018.1500173.
  • Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145(1):24–33. doi:10.1111/j.1365-2141.2009.07600.x.
  • Wada H, Thachil J, Di Nisio M, et al, The Scientific and Standardization Committee on DIC of the ISTH. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;11(4):761–767. doi:10.1111/jth.12155.
  • Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol. 2009;22(1):129–136. doi:10.1016/j.beha.2008.12.005.
  • Barbui T, Falanga A. Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost. 2001;27(6):593–604. doi:10.1055/s-2001-18865.
  • Levi M. Management of cancer-associated disseminated intravascular coagulation. Thromb Res. 2016;140 (Suppl 1):S66–S70. doi:10.1016/S0049-3848(16)30101-3.
  • Rajagopal R, Thachil J, Monagle P. Disseminated intravascular coagulation in paediatrics. Arch Dis Child. 2017;102(2):187–193. doi:10.1136/archdischild-2016-311053.
  • Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine. 2014;93(2):100–105. doi:10.1097/MD.0000000000000022.
  • Franchini M, Di Minno MN, Coppola A. Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost. 2010;36(4):388–403. doi:10.1055/s-0030-1254048.
  • Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood. 1992;79(3):543–553. doi:10.1182/blood.V79.3.543.543.
  • Cook DJ, Crowther MA, Meade MO, Douketis J. Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care. 2005;20(4):309–313. doi:10.1016/j.jcrc.2005.09.005.
  • Green D. Management of bleeding complications of hematologic malignancies. Semin Thromb Hemost. 2007;33(4):427–434. doi:10.1055/s-2007-976178.
  • Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med. 1999;340(13):994–1004. doi:10.1056/NEJM199904013401303.
  • Bennett B, Booth NA, Croll A, Dawson AA. The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination. Br J Haematol. 1989;71(4):511–517. doi:10.1111/j.1365-2141.1989.tb06311.x.
  • Andoh K, Kubota T, Takada M, Tanaka H, Kobavashi N, Maekawa T. Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation. Cancer. 1987;59(4):748–754. doi:10.1002/1097-0142(19870215)59:4<748::AID-CNCR2820590414>3.0.CO;2-E.
  • Gralnick HR, Abrell E. Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Br J Haematol. 1973;24(1):89–99. doi:10.1111/j.1365-2141.1973.tb05730.x.
  • Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood. 1988;71(4):870–875. doi:10.1182/blood.V71.4.870.870.
  • Edwards RL, Rickles FR, Moritz TE, et al. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol. 1987;88(5):596–602. doi:10.1093/ajcp/88.5.596.
  • Delaini F, Colucci M, De Bellis Vitti G, et al. Cancer cell procoagulant: a novel vitamin K-dependent activity. Thrombosis Res. 1981;24(3):263–266. doi:10.1016/0049-3848(81)90097-9.
  • Mann G, Reinhardt D, Ritter J, et al. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol. 2001;80(7):417–422. doi:10.1007/s002770100304.
  • Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994;83(1):10–25. doi:10.1182/blood.V83.1.10.10.
  • Dombret H, Scrobohaci ML, Ghorra P, et al. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Leukemia. 1993;7(1):2–9.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012. doi:10.1016/j.jclinepi.2009.06.005.
  • National Heart LaBi. Study Quality Assessment Tools. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
  • Rajpurkar M, Alonzo TA, Wang YC, et al. Risk markers for significant bleeding and thrombosis in pediatric acute promyelocytic leukemia; Report from the Children’s Oncology Group Study AAML0631. J Pediatr Hematol/Oncol. 2018;41(1):51–55. doi:10.1097/MPH.0000000000001280.
  • Imaizumi M, Tawa A, Hanada R, et al. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: The Japanese childhood acute myeloid leukaemia cooperative study. Br J Haematol. 2011;152(1):89–98. doi:10.1111/j.1365-2141.2010.08332.x.
  • Fenaux P, Vandenbossche-Simon L, Pollet JP, Nelken B, Zandecki M, Bauters F. Acute promyelocytic leukemia in children: A report on eleven cases. Leukemia Lymphoma. 1990;2(6):399–405. doi:10.3109/10428199009069293.
  • Zubizarreta PA, Rose AB, Felice MS, et al. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule. Pediatr Hematol Oncol. 2000;17(2):155–162. doi:10.1080/088800100276514.
  • Chan KW, Steinherz PG, Miller DR. Acute promyelocytic leukemia in children. Med Pediatr Oncol. 1981;9(1):5–15. doi:10.1002/mpo.2950090103.
  • Rovelli A, Biondi A, Rajnoldi AC, et al. Microgranular variant of acute promyelocytic leukemia in children. J Clin Oncol. 1992;10(9):1413–1418. doi:10.1200/JCO.1992.10.9.1413.
  • Farah RA, Horkos JG, Bustros YD, Farhat HZ, Abla O. A Multicenter experience from Lebanon in childhood and adolescent acute myeloid leukemia: High rate of early death in childhood acute promyelocytic leukemia. Mediterr J Hematol Infect Dis. 2014;7(1):e2015012. doi:10.4084/mjhid.2015.012.
  • Xu XJ, Tang YM, Song H, Yang SL, Shi SW, Wei J. Long-term outcome of childhood acute myeloid leukemia in a developing country: Experience from a children’s hospital in China. Leukemia Lymphoma. 2010;51(12):2262–2269. doi:10.3109/10428194.2010.518653.
  • Higuchi T, Toyama D, Hirota Y, et al. Disseminated intravascular coagulation complicating acute lymphoblastic leukemia: a study of childhood and adult cases. Leukemia Lymphoma. 2005;46(8):1169–1176. doi:10.1080/10428190500102662.
  • Champion LA, Luddy RE, Schwartz AD. Disseminated intravascular coagulation in childhood acute lymphocytic leukemia with poor prognostic features. Cancer. 1978;41(4):1642–1646. doi:10.1002/1097-0142(197804)41:4<1642::AID-CNCR2820410456>3.0.CO;2-R.
  • Yang X, Lu J, He H, et al. Complications and outcomes of pediatric patients with hyperleukocytic acute lymphoblastic leukemia with CCLG-2008 protocol. Int J Clin Exp Med. 2016;9(2):3324–3333.
  • Gralnick HR, Marchesi S, Givelber H. Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities. Blood. 1972;40(5):709–718. doi:10.1182/blood.V40.5.709.709.
  • Ribeiro RC, Pui CH. The clinical and biological correlates of coagulopathy in children with acute leukemia. JCO. 1986;4(8):1212–1218. doi:10.1200/JCO.1986.4.8.1212.
  • Yagasaki H, Kato M, Shimozawa K, et al. Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: A single institution experience. Thrombosis Res. 2012;130(6):e289–e93. doi:10.1016/j.thromres.2012.10.004.
  • Abshire TC, Gold SH, Odom LF, Carson SD, Hathaway WE. The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis? Cancer. 1990;66(4):716–721. doi:10.1002/1097-0142(19900815)66:4<716::AID-CNCR2820660420>3.0.CO;2-B.
  • Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children’s Cancer Group study. JCO. 2000;18(3):477–486. doi:10.1200/JCO.2000.18.3.477.
  • Hatae Y, Takeda T, Hattori T, Nakadate H, Nishi M. Advanced neuroblastoma and disseminated intravascular coagulation: report of six cases. Jpn J Clin Oncol. 1985;15(3):483–488.
  • Scott JP, Morgan E. Coagulopathy of disseminated neuroblastoma. J Pediatr. 1983;103(2):219–222. doi:10.1016/S0022-3476(83)80348-5.
  • Rabeh W, Akel S, Eid T, et al. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials. Hematol/Oncol Stem Cell Ther. 2016;9(1):20–25. doi:10.1016/j.hemonc.2015.12.006.
  • Ishihara T, Nogami K, Takeshita Y, Ochi S, Shima M. Fibrinolytic abnormality associated with progression of pediatric solid tumor. Pediatrics Int. 2018;60(6):540–546. doi:10.1111/ped.13546.
  • Hathaway WE, Hays T. Hypercoagulability in childhood cancer. J Pediatr Surg. 1975;10(6):893–899. doi:10.1016/S0022-3468(75)80092-3.
  • Sills RH, Stockman 3rd JA, Miller ML, Stuart MJ. Consumptive coagulopathy. A complication of therapy of solid tumors in childhood. Am J Dis Child. 1978;132(9):870–872. doi:10.1001/archpedi.1978.02120340046008.
  • Komp DM. Lack of thrombohemorrhagic phenomena complicating childhood solid tumors. Cancer. 1974;33(4):1086–1090. doi:10.1002/1097-0142(197404)33:4<1086::AID-CNCR2820330429>3.0.CO;2-V.
  • Krishnan Y, Smitha B, Sreedharan PS. Consumption coagulopathy in paediatric solid tumours: A retrospective analysis and review of literature. Gulf J Oncolog. 2019;1(31):66–71.
  • Papageorgiou C, Jourdi G, Adjambri E, et al. Disseminated intravascular coagulation: An update on pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost. 2018;24:8S–28S. doi:10.1177/1076029618806424.
  • Taylor FB, Jr., Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(11):1327–1330. doi:10.1055/s-0037-1616068.
  • Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol. 1983;(49):265–275.
  • Asakura H, DIC subcommittee of the Japanese Society on Thrombosis and Hemostasis, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016;14:42. doi:10.1186/s12959-016-0117-x.
  • Ikezoe T. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin. Int J Hematol. 2014;100(1):27–37. doi:10.1007/s12185-013-1463-0.
  • Lichtman MA, Rowe JM. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. Blood. 1982;60(2):279–283. doi:10.1182/blood.V60.2.279.279.
  • Lowe EJ, Pui CH, Hancock ML, Geiger TL, Khan RB, Sandlund JT. Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer. 2005;45(1):10–15. doi:10.1002/pbc.20178.
  • Wada H, Asakura H, Okamoto K, et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thrombosis Res. 2010;125(1):6–11. doi:10.1016/j.thromres.2009.08.017.
  • Di Nisio M, Baudo F, Cosmi B, et al. Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thrombosis Res. 2012;129(5):e177–84. doi:10.1016/j.thromres.2011.08.028.
  • Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122(1):10–23.
  • Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care. 2014;2(1):15. doi:10.1186/2052-0492-2-15.
  • Wilde JT, Davies JM. Haemostatic problems in acute leukaemia. Blood Rev. 1990;4(4):245–251. doi:10.1016/0268-960X(90)90004-C.
  • Gregory J, Feusner J. Acute promyelocytic leukemia in childhood. Curr Oncol Rep. 2009;11(6):439–445. doi:10.1007/s11912-009-0060-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.